Europska Unija - hrvatski - EMA (European Medicines Agency)

serb sa - betaine - homocistinuriju - drugi gastrointestinalni trakt i metabolizam, lijekovi, - amversio is indicated as adjunctive treatment of homocystinuria, involving deficiencies or defects in:•         cystathionine beta-synthase (cbs),•         5,10 methylene tetrahydrofolate reductase (mthfr),•         cobalamin cofactor metabolism (cbl).

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

mylan hrvatska d.o.o., koranska 2, zagreb, hrvatska - olanzapin - raspadljiva tableta za usta - 10 mg - urbroj: svaka raspadljiva tableta za usta sadrži 10 mg olanzapina

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

mylan hrvatska d.o.o., koranska 2, zagreb, hrvatska - olanzapin - raspadljiva tableta za usta - 5 mg - urbroj: svaka raspadljiva tableta za usta sadrži 5 mg olanzapina

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

nobel lijek d.o.o. sarajevo - ciprofloksacin - film tableta - 500 mg/1 tableta - 1 film tableta sadrži: 500 mg ciprofloksacina (u obliku ciprofloksacinhidrohlorid, monohidrata)

Europska Unija - hrvatski - EMA (European Medicines Agency)

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastična sredstva - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Europska Unija - hrvatski - EMA (European Medicines Agency)

yes pharmaceutical development services gmbh - doksorubicin hidroklorid - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastična sredstva - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - olanzapin - raspadljiva tableta za usta - 10 mg - urbroj: jedna raspadljiva tableta za usta sadrži 10 mg olanzapina

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb - olanzapinum - raspadljiva tableta za usta - 15 mg - urbroj: jedna raspadljiva tableta za usta sadrži 15 mg olanzapina

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb - olanzapinum - raspadljiva tableta za usta - 20 mg - urbroj: jedna raspadljiva tableta za usta sadrži 20 mg olanzapina

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - olanzapin - raspadljiva tableta za usta - 5 mg - urbroj: jedna raspadljiva tableta za usta sadrži 5 mg olanzapina